Guardant Health Liquid Biopsy

Filter Type: All Time Past 24 Hours Past Week Past month

Listing Results guardant health liquid biopsy

Guardant Health – Conquering Cancer with Data Guardant

Guardant Guardanthealth.com Get All

(855) 698-88877 hours agoGuardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Link to: COVID-19 Response. COVID-19 Update. How Guardant Health is supporting cancer care during the pandemic. Conquering Cancer with Data.

Estimated Reading Time: 1 min
1. JobsGuardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063 Telephone: …
2. Our CompanyGuardant Health is a leading precision oncology company dedicated to helping …
3. Investor RelationsGuardant Health is a leading precision oncology company focused on helping …
4. Contact UsGuardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063 Telephone: …
5. SolutionsThe Guardant360 TissueNext™ test can be ordered alongside our Guardant360 CDx …
6. Stock Quote & ChartAt Guardant Health Inc., we promise to treat your data with respect and will not share …
7. Liquid Biopsy Myths DispelledWe refer to Guardant360 as biopsy‐free testing instead of as a liquid biopsy. This is an …
8. Clinical StudiesClinical Research Guardant Health's clinical research portfolio is helping to transform the …
9. InternationalGuardant Health currently markets its tests in more than 60 countries outside the United …
10. MediaGuardant Health is pleased to provide media professionals with the latest news, …
11. Facebook (4)505 Penobscot Dr, Redwood City, CA 94063 · (855) 698-8887DIRECTIONSWEBSITE

Link: https://guardanthealth.com/

Category: Example of guardant health resultsShow more

Liquid Biopsy Myths Dispelled Guardant Health

Liquid Guardanthealth.com Get All

5 hours ago

Estimated Reading Time: 3 mins
1. Liquid Biopsies Are Always Non-invasive. The term liquid biopsy can be used for any type of specimen other than tissue — including blood, urine, and cerebral spinal fluid — that can be interrogated regarding the functionality of a cancer tumor.
2. All Liquid Biopsies Interrogate the Same Biomarkers. There are two main types of biomarkers interrogated for by liquid biopsies: cell‐free DNA (also known as circulating tumor DNA) and circulating tumor cells (CTCs).
3. All Liquid Biopsies Are Tested the Same Way. All liquid biopsies are not tested in the same way. Comprehensiveness is one differentiating factor.
4. These Tests are Only Available Today for Research or are Still in Development. Guardant360, the most advanced non‐invasive tumor genomic test, is available today and used on a daily basis for clinical testing of cancer patients.

Link: https://guardanthealth.com/contact/liquid-biopsy-myths-dispelled/

Category: Guardant health 360 cdxShow more

The first bloodonly liquid biopsy test Guardant Health

The Guardanthealth.com Get All

3 hours agoGuardant Reveal™ is the first liquid biopsy test that detects residual and recurrent disease in 7 days from a simple blood draw, helping to answer these questions by serving as a: • Risk assessment tool that identifies high-risk patients who are most likely to recur and may benefit most from

Link: https://guardanthealth.com/wp-content/uploads/Backgrounder-Guardant-Reveal-2.10.pdf

Category: Guardant health 360Show more

Guardant – Guardant360 Liquid Biopsy Assay Guardant Health

Guardant Guardanthealth.eu Get All

6 hours agoin 7 days with Liquid Biopsy. Comprehensive genomic profiling from to stay up to date with information on Liquid Biopsy and Guardant Health services. Patient. Physician I agree targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating tumor DNA. Clin Cancer Res. 2016;(22

Link: https://guardanthealth.eu/

Category: Guardant health testingShow more

Guardant360 CDx

CDx Guardant360cdx.com Get All

6 hours agoGuardant360 CDx is: First FDA-approved comprehensive liquid biopsy. Complete genomic results in 7 days. Medicare-covered for all solid tumors, regardless of tissue availability. Seamlessly integrate Guardant360 CDx into your practice. Comprehensive support and educational resources for you and your patients. Find out more.

Link: http://guardant360cdx.com/

Category: Cats Health, Education Health, Medicare HealthShow more

Guardant Health ASCO 2021

Guardant Guardanthealthasco2021.com Get All

5 hours agoGuardant Health’s portfolio of liquid biopsies, provide valuable insights that have a meaningful impact on patients at all stages of the disease. Proof Point 1 Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Link: https://guardanthealthasco2021.com/

Category: Health InsuranceShow more

Patient Guide for Genomic Testing With Liquid Biopsy

Patient Guardant360cdx.com Get All

855.698.88874 hours agoGuardant Access. To enroll in the Guardant Access program, sign the test order form provided by your doctor. If you are unsure if you signed the form, contact Guardant Health Patient Support . via phone at 855.698.8887 or via email at [email protected], and we will enroll you in the program. Visit the myGuardant patient portal to

Link: https://guardant360cdx.com/wp-content/uploads/2020/09/Patient-Brochure.pdf

Category: Health InsuranceShow more

Solutions Guardant Health

Solutions Guardanthealth.com Get All

7 hours ago

Estimated Reading Time: 10 mins

Link: https://guardanthealth.com/solutions/

Category: Health InsuranceShow more

Guardant Health, Inc. Guardant Health Showcases Data at

Guardant Investors.guardanthealth.com Get All

2 hours agoGuardantINFORM™ clinical-genomic liquid biopsy dataset underscores need to improve HER-2 directed treatment in metastatic colorectal cancer Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importance, treatment resistance patterns, and advantages of using the Guardant360 ® liquid biopsy

Link: https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Showcases-Data-at-ESMO-2021-Demonstrating-Utility-of-Guardant360-Liquid-Biopsy-to-Obtain-Comprehensive-Molecular-Information-to-Guide-Targeted-Therapy-Options-for-Late-Stage-Cancers/default.aspx

Category: Mens Health, Health InsuranceShow more

Videos Guardant360 Liquid Biopsy Assay Guardant Health

Videos Guardanthealth.eu Get All

44 808 1893 hours agoGuardant360 – Liquid Biopsy. Guardant360 – Comprehensive Genomic Profiling Blood Test. Guardant Health – ISLB Annual Congress – Satellite Symposium +44 808 189 5057 (toll free) [email protected]; Guardant Health. 505 Penobscot Dr. …

Link: https://guardanthealth.eu/videos/

Category: Health InsuranceShow more

Guardant Health, Inc. CORRECTING and REPLACING Study

Guardant Investors.guardanthealth.com Get All

8 hours agoGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced stage cancer patients, and Guardant Reveal ™ test for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals

Link: https://investors.guardanthealth.com/press-releases/press-releases/2021/CORRECTING-and-REPLACING-Study-Shows-Guardant-Reveal-Blood-Only-Liquid-Biopsy-Test-Predicts-Risk-for-Colorectal-Cancer-Recurrence-with-Industry-Leading-Sensitivity/default.aspx

Category: Mens Health, Health InsuranceShow more

Guardant Health, Inc. Guardant Health Announces

Guardant Investors.guardanthealth.com Get All

5 hours agoThe Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 and GuardantOMNI ® tests for advanced stage cancer patients. These tests fuel

Link: https://investors.guardanthealth.com/press-releases/press-releases/2020/Guardant-Health-Announces-Collaboration-with-Radius-Health-to-Develop-Liquid-Biopsy-Companion-Diagnostic-for-Elacestrant/default.aspx

Category: Health InsuranceShow more

Study Shows Guardant Reveal™ BloodOnly Liquid Biopsy Test

Study Apnews.com Get All

3 hours agoThe single-center, prospective study evaluated the effectiveness of the Guardant Reveal liquid biopsy test to detect MRD in patients with stage I-IV colorectal cancer after curative intent therapy. Blood draws were taken one month after completion of definitive treatment, either surgery or adjuvant therapy, and at various surveillance or

Link: https://apnews.com/press-release/business-wire/cancer-health-8ca95aaf65244f56948f24a3c59be420

Category: Mens HealthShow more

Guardant scores FDA approval for liquid biopsy test

Guardant Medcitynews.com Get All

4 hours agoGuardant scores FDA approval for liquid biopsy test In a phone interview, Guardant Health CEO Helmy Eltoukhy said he expected the approval to encourage coverage by …

Estimated Reading Time: 2 mins

Link: https://medcitynews.com/2020/08/guardant-scores-fda-approval-for-liquid-biopsy-test/

Category: Health InsuranceShow more

LUNG FORCE Walk Buffalo: Guardant Health Liquid

LUNG Action.lung.org Get All

8 hours agoLiquid Biopsies. Learn about liquid biopsies with LUNG FORCE Sponsor Guardant Health. What is a liquid biopsy? A liquid biopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or for pieces of DNA from tumor cells that are in the blood.

Link: https://action.lung.org/site/TR?pg=informational&fr_id=21952&sid=12371

Category: Lung Cancer Health, Health InsuranceShow more

Guardant Health’s comprehensive liquid biopsy test

Guardant Economictimes.indiatimes.com Get All

9 hours agoThe Guardant360 liquid biopsy test offered by Guardant Health AMEA has shown high agreement with tissue biopsies in detecting actionable mutations and this has helped to guide treatment decisions for patients with advanced-stage cancer.

Link: https://economictimes.indiatimes.com/magazines/panache/guardant-healths-comprehensive-liquid-biopsy-test-guardant360-provides-quick-and-reliable-treatment-decisions-for-patients-with-advanced-stage-cancer/articleshow/86395381.cms

Category: Mens Health, Health InsuranceShow more

Guardant Health Showcases Data at ESMO 2021 Demonstrating

Guardant Finance.yahoo.com Get All

1 hours agoCell-free DNA dominant clone allele frequency associates with poor outcomes in advanced pancreatic cancer. benefits and advantages of Guardant Health’s liquid biopsy

Link: https://finance.yahoo.com/news/guardant-health-showcases-data-esmo-080000961.html

Category: Health InsuranceShow more

Guardant Health, Inc. Guardant Health Expands

Guardant Investors.guardanthealth.com Get All

Just NowGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI ® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to

Link: https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Expands-Guardant360-Portfolio-With-New-Tests-for-Treatment-Response-Monitoring-and-Complete-Genomic-Profiling/default.aspx

Category: Mens Health, Health InsuranceShow more

Data at AACR Demonstrate Growing Clinical Utility of

Data Businesswire.com Get All

3 hours agoGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced-stage cancer patients, and Guardant Reveal ™ test for early

Link: https://www.businesswire.com/news/home/20210410005027/en/Data-at-AACR-Demonstrate-Growing-Clinical-Utility-of-Guardant-Health-Liquid-Biopsies-in-the-Treatment-and-Management-of-Advanced-Cancers

Category: Health InsuranceShow more

Guardant Health Showcases Data at ESMO 2021 Demonstrating

Guardant Morningstar.com Get All

9 hours agoGuardant Health Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360 ® Liquid Biopsy to Obtain Comprehensive Molecular Information to Guide Targeted Therapy Options for …

Link: https://www.morningstar.com/news/business-wire/20210915005307/guardant-health-showcases-data-at-esmo-2021-demonstrating-utility-of-guardant360-liquid-biopsy-to-obtain-comprehensive-molecular-information-to-guide-targeted-therapy-options-for-late-stage-cancers

Category: Health InsuranceShow more

Guardant Health Liquid Biopsy Test Improves

Guardant Precisiononcologynews.com Get All

8 hours agoGuardant Health Liquid Biopsy Test Improves Gastrointestinal Cancer Clinical Trial Enrollment The researchers also compared the objective response rates and progression-free survival among patients screened by these two approaches to see whether the testing method makes a difference. Both groups had similar objective response rates and

Link: https://www.precisiononcologynews.com/cancer/guardant-health-liquid-biopsy-test-improves-gastrointestinal-cancer-clinical-trial-enrollment

Category: Mens Health, Health InsuranceShow more

Global $25 Billion Liquid Biopsy Markets Outlook to 2028

Global Finance.yahoo.com Get All

7 hours agoThe global liquid biopsy market attained revenue of close to USD 3160 Million in 2019 and is estimated to garner over USD 25800 Million in 2028. Scientific, Guardant Health

Link: https://finance.yahoo.com/news/global-25-billion-liquid-biopsy-080300029.html

Category: Health InsuranceShow more

Guardant Health: Profiting From Precision Medicine (NASDAQ

Guardant Seekingalpha.com Get All

12.29.235Just Now

1. As usual, I'll deliver a brief corporate overview for new investors. If you are familiar with the firm, I suggest that you skip to the subsequent section. Operating out of Redwood City California, Guardant Healthis a leading medical diagnostics innovator. The company is focused on the development and commercialization of genetic profiling to enhance treatment outcomes of various cancers. Through the Guardant Health Oncology platform, the firm launched liquid biopsy diagnostics consisting of Guardant360 and GuardantOMNI to catch all stages of cancers. Figure 2: Diagnostic pipeline (Source: Guardian Health) Since its birth in 2014, Guardant's liquid biopsy is taking the market by storm. Specifically, Guardant360 and GuardantOMNI are being utilized by more than 5K cancer specialists, 40 life science companies, and the whole National Comprehensive Cancer Network centers. Regarding pipeline development, Guardant is tinkering with LUNAR-1 and -2 for detecting cancer recurrences and early-...
Estimated Reading Time: 9 mins

Link: https://seekingalpha.com/article/4272683-guardant-health-profiting-from-precision-medicine

Category: Health InsuranceShow more

Guardant360 ® CDx Liquid Biopsy CEMarked for

CDx Businesswire.com Get All

Just NowGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced stage cancer patients, and Guardant Reveal ™ for early-stage

Link: https://www.businesswire.com/news/home/20210302005363/en/Guardant360®-CDx-Liquid-Biopsy-CE-Marked-for-Comprehensive-Tumor-Mutation-Profiling-Across-All-Solid-Cancers

Category: Health InsuranceShow more

Global Liquid Biopsy Market Report 20212028 Featuring

Global Prnewswire.com Get All

3 hours ago4 hours ago · Global Liquid Biopsy Market Report 2021-2028 Featuring Qiagen, F. Hoffmann-La Roche, Bio-Rad Laboratories, Illumina, Inivata, Agena Bioscience, Thermo Fisher Scientific, Guardant Health

Link: https://www.prnewswire.com/news-releases/global-liquid-biopsy-market-report-2021-2028-featuring-qiagen-f-hoffmann-la-roche-bio-rad-laboratories-illumina-inivata-agena-bioscience-thermo-fisher-scientific-guardant-health-301384651.html

Category: Health InsuranceShow more

Guardant Health Launches Guardant Reveal™ Liquid Biopsy

Guardant Nasdaq.com Get All

9 hours agoGuardant Health, Inc., a leading precision oncology company, announced the availability of Guardant Reveal™, the first blood-only liquid biopsy test for the detection of residual and recurrent

Link: https://www.nasdaq.com/press-release/guardant-health-launches-guardant-revealtm-liquid-biopsy-test-for-residual-disease

Category: Health InsuranceShow more

CORRECTING and REPLACING Study Shows Guardant Reveal

and Businesswire.com Get All

9 hours agoGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced stage cancer patients, and Guardant Reveal ™ test for early

Link: https://www.businesswire.com/news/home/20210430005142/en/CORRECTING-and-REPLACING-Study-Shows-Guardant-Reveal™-Blood-Only-Liquid-Biopsy-Test-Predicts-Risk-for-Colorectal-Cancer-Recurrence-with-Industry-Leading-Sensitivity

Category: Health InsuranceShow more

Liquid Biopsy market are also anticipated to record steady

Liquid Tsnewswire.com Get All

6 hours agoGuardant Health, Personal Genome Diagnostics, Biocept, Adaptive Biotechnologies, By saddam Sep 22, 2021 Liquid Biopsy market Share. Global Liquid Biopsy market provides an in-depth insight into the global market covering all its important chapters which are must read for key industry stakeholders. Report coverage include historical market

Link: http://tsnewswire.com/2021/09/liquid-biopsy-market-are-also-anticipated-to-record-steady-sales-growth-2025-key-players-guardant-health-personal-genome-diagnostics-biocept-adaptive-biotechnologies/

Category: Personal Healthcare, Health InsuranceShow more

Study Shows Guardant360 Liquid Biopsy Predicts Response to

Study Businesswire.com Get All

4 hours agoGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced stage cancer patients, and Guardant Reveal ™ test for early

Link: https://www.businesswire.com/news/home/20210326005031/en/Study-Shows-Guardant360-Liquid-Biopsy-Predicts-Response-to-Pembrolizumab-Based-Immunotherapy-in-Patients-with-Metastatic-Non-Small-Cell-Lung-Cancer

Category: Health InsuranceShow more

Minimum Technical Data Elements for Liquid Biopsy Data

Data Ncbi.nlm.nih.gov Get All

4 hours agoMinimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. (1)Illumina, San Diego, California, USA. (2)Novartis Pharmaceuticals, East Hanover, New Jersey, USA. (3)Memorial Sloan Kettering Cancer Center, New York, New York, USA. (4)AstraZeneca, Waltham, Massachusetts, USA.

Link: https://www.ncbi.nlm.nih.gov/pubmed/32017048

Category: Mens HealthShow more

Liquid Biopsy Products Market Supply Chain Analysis 2021

Liquid Manometcurrent.com Get All

Just NowThe global Liquid Biopsy Products market contains different market players such as: RainDanceTechnologies Biocartis Qiagen Guardant Health MDxHealth Pathway Genomics NeoGenomics Laboraories Sysmex Inostics Cynvenio Menarini Silicon Biosystems Adaptive Biotechnologies Biocept Angle plc. The global Liquid Biopsy Products market types, is divided

Link: https://manometcurrent.com/liquid-biopsy-products-market-supply-chain-analysis-2021-28-qiagen-guardant-health-mdxhealth/

Category: Mens Health, Health InsuranceShow more

Guardant Health Presents Data at 2021 ASCO Annual Meeting

Guardant Businesswire.com Get All

Just NowGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced stage cancer patients, and Guardant Reveal ™ test for early

Link: https://www.businesswire.com/news/home/20210519005968/en/Guardant-Health-Presents-Data-at-2021-ASCO-Annual-Meeting-Showing-Utility-of-Liquid-Biopsy-in-Early--and-Late-Stage-Cancers

Category: Health InsuranceShow more

Guardant Health Showcases Data at ESMO 2021 Demonstrating

Guardant Biospace.com Get All

Just NowGuardant Health, Inc., along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importance, treatment resistance patterns, and advantages of using the Guardant360® liquid biopsy test to help improve the management of advanced solid cancers at the European Society for Medical Oncology

Link: https://www.biospace.com/article/releases/guardant-health-showcases-data-at-esmo-2021-demonstrating-utility-of-guardant360-liquid-biopsy-to-obtain-comprehensive-molecular-information-to-guide-targeted-therapy-options-for-late-stage-cancers/

Category: Mens Health, Health InsuranceShow more

Guardant companion diagnostic gets FDA nod as 1st liquid

Guardant Medtechdive.com Get All

3 hours agoDive Brief: FDA Friday approved Guardant Health's liquid biopsy diagnostic that uses next-generation sequencing (NGS) to identify patients with mutations of the epidermal growth factor receptor (EGFR) gene in metastatic non-small cell lung cancer. It is the first time the two technologies have been combined in one diagnostic test, the agency said. The Guardant360 CDx assay was …

Link: https://www.medtechdive.com/news/guardant-companion-diagnostic-gets-fda-nod-as-1st-liquid-biopsy-with-ngs/583198/

Category: Lung Cancer Health, Health InsuranceShow more

Guardant Health Expands Guardant360® Portfolio With New

Guardant Finance.yahoo.com Get All

1 hours agoGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI ® tests for advanced stage

Link: https://finance.yahoo.com/news/guardant-health-expands-guardant360-portfolio-120500253.html

Category: Health InsuranceShow more

Guardant Health Guardant360 CDx First FDAApproved Liquid

Guardant Spjnews.com Get All

8 hours agoThe Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 ® and GuardantOMNI ® tests for advanced stage cancer patients. These tests fuel

Estimated Reading Time: 5 mins

Link: https://www.spjnews.com/2020/08/11/guardant-health-guardant360-cdx-first-fda-approved-liquid-biopsy-for-comprehensive-tumor-mutation-profiling-across-all-solid-cancers/

Category: Health InsuranceShow more

Guardant Health, Inc. Guardant Health Data at ASCO and

Guardant Investors.guardanthealth.com Get All

4 hours agoThe Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 and GuardantOMNI tests for advanced stage cancer patients.

Link: https://investors.guardanthealth.com/press-releases/press-releases/2020/Guardant-Health-Data-at-ASCO-and-AACR-Demonstrates-Growing-Value-of-Liquid-Biopsy-for-Precision-Oncology-in-Advanced-and-Early-Stage-Cancer/default.aspx

Category: Health InsuranceShow more

Guardant360 CDx Advanced Solid Tumor Patients Deserve a

CDx Guardant360cdx.com Get All

8 hours agoGuardant360 CDx is the first comprehensive liquid biopsy approved by the FDA 17 and administered through mobile or in-office phlebotomy to facilitate guideline-recommended genomic results in just 7 days. The assay uses proprietary next-generation sequencing technology to simultaneously detect mutations in a broad panel of clinically-relevant

Link: https://guardant360cdx.com/advanced-solid-tumor-patients-deserve-a-blood-first-paradigm/

Category: Mens HealthShow more

Guardant Health Showcases Data at ESMO 2021 Demonstrating

Guardant Streetinsider.com Get All

1 hours agoGuardantINFORM clinical-genomic liquid biopsy dataset underscores need to improve HER-2 directed treatment in metastatic colorectal cancer REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health

Link: https://www.streetinsider.com/Business Wire/Guardant Health Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360® Liquid Biopsy to Obtain Comprehensive Molecular Information to Guide Targeted Therapy Options for Late-Stage Cancers/18940906.html

Category: Mens Health, Health InsuranceShow more

Guardant Hits Milestone with FDA Nod for Liquid Biopsy

Guardant Mddionline.com Get All

1 hours agoGuardant Health has hit an important milestone with its liquid biopsy test. The Redwood City, CA-based company won a nod from FDA for the Guardant360 CDX, making it the first liquid biopsy test for comprehensive tumor mutation profiling across all solid cancers to obtain approval.

Estimated Reading Time: 4 mins

Link: https://www.mddionline.com/ivd/guardant-hits-milestone-fda-nod-liquid-biopsy-test

Category: Health InsuranceShow more

Guardant360® CDx Receives FDA Approval as First and Only

CDx Streetinsider.com Get All

4 hours agoGuardant Health liquid biopsy can help identify the 13 percent of patients harboring the KRAS G12C mutation, a previously undruggable target, who may be appropriate for LUMAKRAS. REDWOOD CITY

Link: https://www.streetinsider.com/Business Wire/Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen’s LUMAKRAS™ (sotorasib) KRASG12C Inhibitor for Use in Advanced Non-Small Cell Lung Cancer/18494185.html

Category: Health InsuranceShow more

Global and United States Breast Cancer Liquid Biopsy

Global Reportsnreports.com Get All

7 hours agoTable 114. Guardant Health Breast Cancer Liquid Biopsy Product Table 115. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 116. Guardant Health Recent Development Table 117. RainDance Technologies Company Details Table 118. RainDance Technologies Business Overview Table 119.

Link: https://www.reportsnreports.com/reports/4894773-global-and-united-states-breast-cancer-liquid-biopsy-market-size-status-and-forecast-2021-2027.html

Category: Breast Cancer Health, Mens Health, Health InsuranceShow more

Liquid Biopsy Testing – Solid Tumors

Liquid Evicore.com Get All

9 hours agoThis policy also does not address the use of ctDNA as a liquid biopsy in hematological malignancies. Test information Testing methodology relies on the presence of ctDNA in circulation. Various laboratories have recently developed liquid biopsy tests (e.g. Guardant Health, Trovagene, Biocept, Transgenomic).

Link: https://www.evicore.com/-/media/files/evicore/clinical-guidelines/solution/lab-management/healthplan/liquid-biopsy-testing-solid-tumors.pdf

Category: Health InsuranceShow more

Guardant Health Showcases Data at ESMO 2021 Demonstrating

Guardant Aijourn.com Get All

9 hours agoREDWOOD CITY, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importance, treatment resistance patterns, and advantages of using the Guardant360 ® liquid biopsy test to help improve the management of advanced solid cancers at the European Society for Medical

Link: https://aijourn.com/press_release/guardant-health-showcases-data-at-esmo-2021-demonstrating-utility-of-guardant360-liquid-biopsy-to-obtain-comprehensive-molecular-information-to-guide-targeted-therapy-options-for-late-stage-canc/

Category: Mens Health, Health InsuranceShow more

Guardant Health Data at ASCO and AACR Demonstrates Growing

Guardant Nasdaq.com Get All

2 hours agoGuardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer Published May …

Link: https://www.nasdaq.com/press-release/guardant-health-data-at-asco-and-aacr-demonstrates-growing-value-of-liquid-biopsy-for

Category: Health InsuranceShow more

Guardant Health Guardant360® CDx First FDAApproved Liquid

Guardant Nasdaq.com Get All

Just NowSince the company’s inception, Guardant Health has been dedicated to unlocking the potential of liquid biopsy to transform cancer by enabling precision …

Link: https://www.nasdaq.com/press-release/guardant-health-guardant360r-cdx-first-fda-approved-liquid-biopsy-for-comprehensive

Category: Cats Health, Health InsuranceShow more

CORRECTING and REPLACING Guardant Health Presents Data at

and Streetinsider.com Get All

6 hours agoGuardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ test for early

Link: https://www.streetinsider.com/Business Wire/CORRECTING and REPLACING Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers/18578450.html

Category: Health InsuranceShow more

Guardant Health Sues Foundation Medicine for False

Guardant Genomeweb.com Get All

8 hours agoGuardant and Foundation became rivals in the liquid biopsy space when Foundation launched and began marketing its blood-based FoundationACT last year. More recently, Foundation sued Guardant , alleging infringement of US Patent No. 9,340,830, which covers methods for analyzing a cancer patient's tissue or blood sample to detect multiple classes

Link: https://www.genomeweb.com/business-news/guardant-health-sues-foundation-medicine-false-advertising

Category: Beauty Spa, Mens Health, Spa Healthcare, Health InsuranceShow more

Filter Type: All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Frequently Asked Questions

What is guardant testing?

Guardant makes a "liquid biopsy" test, called Guardant360, that uses blood samples from cancer patients and sequences the genetic information in that blood to figure out what might be the best way to treat a certain tumor.

How much does a liquid biopsy cost?

Whether liquid biopsies will be cost-effective is unknown. Guardant’s test costs $5,400; some insurers cover it for certain types of patients. Gene profiling from a tissue biopsy costs about the same. The promise of liquid biopsies is that they can be done periodically to monitor care, but more tests means more cost.

Is liquid biopsy the future of cancer diagnostics?

In the future, researchers envision that a liquid biopsy test that screens for the most common types of cancer would be integrated into a yearly physical checkup. While many companies are focusing on developing tests to detect certain groups of cancer types, others want to create a single test designed to catch a broad array.

What is a liquid biopsy cancer test?

A liquid biopsy is a test that is used to find evidence of cancer in a blood draw.

New Post

Most Popular Search